Mar 16, 2017

Seeking the Elusive Long-Acting Ozonide: Discovery of Artefenomel (OZ439)

Journal of Medicinal Chemistry
Ho Shin KimR Kiplin Guy

Abstract

The majority of frontline therapies for the treatment of malaria are combination drugs containing artemisinin (or its semisynthetic analogs), known as artemisinin combination therapies (ACTs). While generally efficacious, ACTs and the first generation fully synthetic ozonide, arterolane (OZ277, 1), suffer from rapid clearance requiring 3-day dosing regimens. Extensive structure-activity studies led to the discovery of a second-generation ozonide, artefenomel (OZ439, 2), which has overcome this limitation, maintaining the rapid onset of action and potent activity of the artemisinin derivatives while exhibiting greatly improved pharmacokinetics, low projected cost of goods, prophylactic activity, and the potential for a single dose cure.

  • References7
  • Citations3

References

  • References7
  • Citations3

Citations

Mentioned in this Paper

Treatment Protocols
Derivatives
Combination Drug Therapy
Analog
Malaria
Malaria Vaccines
OZ 277
Pharmacologic Substance
Adamantane
Coitus

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.